News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
128 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2987)
February (3289)
March (3625)
April (3424)
May (3732)
June (3552)
July (2687)
August (3042)
September (3454)
October (3101)
November (3075)
December (2362)
Day
3 (172)
4 (195)
5 (149)
6 (140)
7 (113)
10 (126)
11 (159)
12 (120)
13 (172)
14 (93)
17 (155)
18 (157)
19 (135)
20 (154)
21 (99)
24 (148)
25 (174)
26 (164)
27 (205)
28 (128)
31 (143)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Theravance Biopharma Announces Pricing Of Public Offerings Of 3,850,000 Ordinary Shares And $200 Million Of 3.25% Convertible Senior Notes Due 2023
October 28, 2016
·
6 min read
Business
Cytokinetics Reports Third Quarter 2016 Financial Results
October 28, 2016
·
1 min read
Business
Aviragen To Host Conference Call To Report First Quarter Fiscal Year 2017 Financial Results On November 3, 2016
October 28, 2016
·
1 min read
Allergan Introduces RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) 0.05%, A New Delivery System For The One And Only FDA Approved Treatment To Help Patients Produce More Of Their Own Tears
October 28, 2016
·
5 min read
Business
New England Biolabs, Inc. Announces Agreement With AmpTec GmbH To Supply Key mRNA Synthesis Reagents
October 28, 2016
·
3 min read
FDA
FDA Green Lights Corindus Vascular Robotics’ Next Generation Robotic System
October 28, 2016
·
6 min read
Business
Levo Therapeutics To License Exclusive Rights To Ferring Pharma’ Orphan-Designated Drug, Carbetocin, For The Treatment Of Prader-Willi Syndrome
October 28, 2016
·
3 min read
Business
Catherine M. Burzik Joins Haemonetics Board Of Directors
October 28, 2016
·
2 min read
FDA
Acella Pharmaceuticals, LLC, Announces Approval Of A Generic Bromfed Antihistamine/Decongestant
October 28, 2016
·
2 min read
Business
Kineticos Life Sciences Consulting Expands Biopharmaceutical Practice Leadership Team, Bolsters Oncology Focus With Senior Vice President Appointment
October 28, 2016
·
3 min read
Previous
6 of 13
Next
